Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Propofol and propofol-ketamine in pediatric patients undergoing cardiac catheterization.

Propofol and propofol-ketamine in pediatric patients undergoing cardiac catheterization. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Propofol and propofol-ketamine in pediatric patients undergoing cardiac catheterization. Abstract Text:

    a akinA Akin,a esmaogluA Esmaoglu,g gulerG Guler,r demirciogluR Demircioglu,n narinN Narin,a boyaciA Boyaci,

    We investigated the effects of propofol and propofol-ketamine on hemodynamics, sedation level, and recovery period in pediatric patients undergoing cardiac catheterization. We performed a prospective, randomized, double-blind study. The study included 60 American Society of Anesthesiologists physical status II or III (age range, 1 month-13 years) undergoing cardiac catheterization for evaluation of congenital heart disease. Propofol and ketamine were prepared in 5% glucose solution to a final concentration of 5 and 1 mg/ml, respectively; similar injectors containing 5% glucose solution only were prepared. Fentanyl (1 microg/kg) and propofol (1.5 mg/kg) were given to both groups. Then, group 1 received 0.5 ml/kg of 5% glucose and group 2 0.5 ml/kg of ketamine solution by an anesthesiologist who was unaware of the groups of patients. Local anesthesia with 1% lidocaine was administered before intervention in all patients. The noninvasively measured mean arterial pressure, heart rate, respiratory rate, and peripheral oxygen saturation were recorded at the baseline, following drug administration, at 3, 5, 10, 15, 20, and 30 minutes and then at 15-minute intervals until the end of the procedure. Additional drug and fentanyl requirements to maintain a sedation level of 4 or 5 were recorded. After the procedure, the time to a Steward recovery score of 6 and adverse effects in the first 24 hours were recorded. The number of patients with more than a 20% decrease in mean arterial pressure was 11 in group 1 and 3 in group 2 (p < 0.05). The number of patients who experienced more than a 20% decrease in heart rate was 12 in group 1 and 5 in group 2 (p = 0.054). Ten patients in group 1 and 3 patients in group 2 required additional fentanyl doses (p = 0.057). The number of additional propofol doses was lower in group 2 (p < 0.05). Propofol combined with low-dose ketamine preserves mean arterial pressure better without affecting the recovery and thus is a good option in pediatric patients undergoing cardiac catheterization.

    Propofol and propofol-ketamine in pediatric patients undergoing cardiac catheterization. Publishing Authors By Initials

    a akinA Akin,a esmaogluA Esmaoglu,g gulerG Guler,r demirciogluR Demircioglu,n narinN Narin,a boyaciA Boyaci,

    For similar circulatory and respiratory physiology: respiratory physiology research abstracts see: circulatory and respiratory physiology: respiratory physiology research

    PUBMED ID PMID:

    MEDLINE DATE: 2005 Sep-Oct

    Propofol and propofol-ketamine in pediatric patients undergoing cardiac catheterization. Journal Published:

    PUBLICATION TYPE: Randomized Controlled Trial

    Journal: Pediatric cardiology

    VOLUME: 26

    Page Numbers: 553-7

    Journal Abbreviation: Pediatr Cardiol

    ISSN: 0172-0643

    DAY: 20

    MONTH: 02

    YEAR: 2008

    Propofol and propofol-ketamine in pediatric patients undergoing cardiac catheterization. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8003849

    Propofol and propofol-ketamine in pediatric patients undergoing cardiac catheterization. Keywords Mesh Terms:

    KEYWORDS: Respiratory Physiology

    MESH TERMS: drug effects

    Chemical & Substance for Abstract: Propofol and propofol-ketamine in pediatric patients undergoing cardiac catheterization. Information

    Substance Name: Ketamine

    Registry Number: 6740-88-1

    Grant and Affiliation Information for Propofol and propofol-ketamine in pediatric patients undergoing cardiac catheterization.

    AFFILIATION: Department of Anesthesiology, Erciyes, University School of Medicine, Kayseri, Turkey. aaynur@erciyes.edu.tr

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Pediatr Cardiol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Propofol and propofol-ketamine in pediatric patients undergoing cardiac catheterization Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News